By Published On: May 5, 2022

ENT & Allergy Deal Activity Cools Off to Begin 2022 Look For Additional PE Investor Interest Ahead

The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.

DOWNLOAD TO READ MORE

Andy Snyder joined FOCUS in 2021 and serves as a Managing Director. During his investment banking career, he has worked on mergers and acquisitions, capital raises, and strategic advisory assignments for a wide range of healthcare companies. His current practice includes healthcare provider services, behavioral health, healthcare facilities, healthcare IT, and medical technology. Prior to joining FOCUS, Snyder served as Managing Director for Physicians First, a boutique firm where he completed a variety of healthcare transactions, many with private equity firms and PE-backed companies. Past clients in this role include leading physician groups, healthcare facilities, and institutional healthcare investors. Snyder received a Master of Business Administration (MBA) from Vanderbilt University and a BA from the University of Virginia. He is a FINRA-licensed investment banker and holds series 63, 79, and 82 licenses. He lives in Nashville with his wife and two children.